The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epoetin-alfa Erythropoietin Market Research Report 2025
Synopsis
The global Epoetin-alfa Erythropoietin market was valued at US$ 5360.1 million in 2023 and is anticipated to reach US$ 7605.5 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
North American market for Epoetin-alfa Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epoetin-alfa Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Epoetin-alfa Erythropoietin include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epoetin-alfa Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin-alfa Erythropoietin.
Report Scope
The Epoetin-alfa Erythropoietin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epoetin-alfa Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epoetin-alfa Erythropoietin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Type
Anemia
Kidney Disorders
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epoetin-alfa Erythropoietin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epoetin-alfa Erythropoietin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Epoetin-alfa Erythropoietin market was valued at US$ 5360.1 million in 2023 and is anticipated to reach US$ 7605.5 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
North American market for Epoetin-alfa Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epoetin-alfa Erythropoietin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Epoetin-alfa Erythropoietin include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epoetin-alfa Erythropoietin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epoetin-alfa Erythropoietin.
Report Scope
The Epoetin-alfa Erythropoietin market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epoetin-alfa Erythropoietin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epoetin-alfa Erythropoietin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Segment by Type
Anemia
Kidney Disorders
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Epoetin-alfa Erythropoietin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Epoetin-alfa Erythropoietin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Epoetin-alfa Erythropoietin Market Overview
1.1 Product Overview and Scope of Epoetin-alfa Erythropoietin
1.2 Epoetin-alfa Erythropoietin Segment by Type
1.2.1 Global Epoetin-alfa Erythropoietin Market Value Comparison by Type (2024-2030)
1.2.2 Anemia
1.2.3 Kidney Disorders
1.2.4 Other
1.3 Epoetin-alfa Erythropoietin Segment by Application
1.3.1 Global Epoetin-alfa Erythropoietin Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Epoetin-alfa Erythropoietin Market Size Estimates and Forecasts
1.4.1 Global Epoetin-alfa Erythropoietin Revenue 2019-2030
1.4.2 Global Epoetin-alfa Erythropoietin Sales 2019-2030
1.4.3 Global Epoetin-alfa Erythropoietin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Epoetin-alfa Erythropoietin Market Competition by Manufacturers
2.1 Global Epoetin-alfa Erythropoietin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Epoetin-alfa Erythropoietin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Epoetin-alfa Erythropoietin Average Price by Manufacturers (2019-2024)
2.4 Global Epoetin-alfa Erythropoietin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Epoetin-alfa Erythropoietin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Epoetin-alfa Erythropoietin, Product Type & Application
2.7 Epoetin-alfa Erythropoietin Market Competitive Situation and Trends
2.7.1 Epoetin-alfa Erythropoietin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Epoetin-alfa Erythropoietin Players Market Share by Revenue
2.7.3 Global Epoetin-alfa Erythropoietin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Epoetin-alfa Erythropoietin Retrospective Market Scenario by Region
3.1 Global Epoetin-alfa Erythropoietin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Epoetin-alfa Erythropoietin Global Epoetin-alfa Erythropoietin Sales by Region: 2019-2030
3.2.1 Global Epoetin-alfa Erythropoietin Sales by Region: 2019-2024
3.2.2 Global Epoetin-alfa Erythropoietin Sales by Region: 2025-2030
3.3 Global Epoetin-alfa Erythropoietin Global Epoetin-alfa Erythropoietin Revenue by Region: 2019-2030
3.3.1 Global Epoetin-alfa Erythropoietin Revenue by Region: 2019-2024
3.3.2 Global Epoetin-alfa Erythropoietin Revenue by Region: 2025-2030
3.4 North America Epoetin-alfa Erythropoietin Market Facts & Figures by Country
3.4.1 North America Epoetin-alfa Erythropoietin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Epoetin-alfa Erythropoietin Sales by Country (2019-2030)
3.4.3 North America Epoetin-alfa Erythropoietin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Epoetin-alfa Erythropoietin Market Facts & Figures by Country
3.5.1 Europe Epoetin-alfa Erythropoietin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Epoetin-alfa Erythropoietin Sales by Country (2019-2030)
3.5.3 Europe Epoetin-alfa Erythropoietin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Epoetin-alfa Erythropoietin Market Facts & Figures by Country
3.6.1 Asia Pacific Epoetin-alfa Erythropoietin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Epoetin-alfa Erythropoietin Sales by Country (2019-2030)
3.6.3 Asia Pacific Epoetin-alfa Erythropoietin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Epoetin-alfa Erythropoietin Market Facts & Figures by Country
3.7.1 Latin America Epoetin-alfa Erythropoietin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Epoetin-alfa Erythropoietin Sales by Country (2019-2030)
3.7.3 Latin America Epoetin-alfa Erythropoietin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Epoetin-alfa Erythropoietin Market Facts & Figures by Country
3.8.1 Middle East and Africa Epoetin-alfa Erythropoietin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Epoetin-alfa Erythropoietin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Epoetin-alfa Erythropoietin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Epoetin-alfa Erythropoietin Sales by Type (2019-2030)
4.1.1 Global Epoetin-alfa Erythropoietin Sales by Type (2019-2024)
4.1.2 Global Epoetin-alfa Erythropoietin Sales by Type (2025-2030)
4.1.3 Global Epoetin-alfa Erythropoietin Sales Market Share by Type (2019-2030)
4.2 Global Epoetin-alfa Erythropoietin Revenue by Type (2019-2030)
4.2.1 Global Epoetin-alfa Erythropoietin Revenue by Type (2019-2024)
4.2.2 Global Epoetin-alfa Erythropoietin Revenue by Type (2025-2030)
4.2.3 Global Epoetin-alfa Erythropoietin Revenue Market Share by Type (2019-2030)
4.3 Global Epoetin-alfa Erythropoietin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Epoetin-alfa Erythropoietin Sales by Application (2019-2030)
5.1.1 Global Epoetin-alfa Erythropoietin Sales by Application (2019-2024)
5.1.2 Global Epoetin-alfa Erythropoietin Sales by Application (2025-2030)
5.1.3 Global Epoetin-alfa Erythropoietin Sales Market Share by Application (2019-2030)
5.2 Global Epoetin-alfa Erythropoietin Revenue by Application (2019-2030)
5.2.1 Global Epoetin-alfa Erythropoietin Revenue by Application (2019-2024)
5.2.2 Global Epoetin-alfa Erythropoietin Revenue by Application (2025-2030)
5.2.3 Global Epoetin-alfa Erythropoietin Revenue Market Share by Application (2019-2030)
5.3 Global Epoetin-alfa Erythropoietin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Epoetin-alfa Erythropoietin Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Epoetin-alfa Erythropoietin Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roche Epoetin-alfa Erythropoietin Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Galenica
6.4.1 Galenica Corporation Information
6.4.2 Galenica Description and Business Overview
6.4.3 Galenica Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Galenica Epoetin-alfa Erythropoietin Product Portfolio
6.4.5 Galenica Recent Developments/Updates
6.5 Emcure
6.5.1 Emcure Corporation Information
6.5.2 Emcure Description and Business Overview
6.5.3 Emcure Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Emcure Epoetin-alfa Erythropoietin Product Portfolio
6.5.5 Emcure Recent Developments/Updates
6.6 Kyowa Hakko Kirin
6.6.1 Kyowa Hakko Kirin Corporation Information
6.6.2 Kyowa Hakko Kirin Description and Business Overview
6.6.3 Kyowa Hakko Kirin Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Kyowa Hakko Kirin Epoetin-alfa Erythropoietin Product Portfolio
6.6.5 Kyowa Hakko Kirin Recent Developments/Updates
6.7 3SBio
6.6.1 3SBio Corporation Information
6.6.2 3SBio Description and Business Overview
6.6.3 3SBio Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 3SBio Epoetin-alfa Erythropoietin Product Portfolio
6.7.5 3SBio Recent Developments/Updates
6.8 Biocon
6.8.1 Biocon Corporation Information
6.8.2 Biocon Description and Business Overview
6.8.3 Biocon Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biocon Epoetin-alfa Erythropoietin Product Portfolio
6.8.5 Biocon Recent Developments/Updates
6.9 LG Life Sciences
6.9.1 LG Life Sciences Corporation Information
6.9.2 LG Life Sciences Description and Business Overview
6.9.3 LG Life Sciences Epoetin-alfa Erythropoietin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 LG Life Sciences Epoetin-alfa Erythropoietin Product Portfolio
6.9.5 LG Life Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Epoetin-alfa Erythropoietin Industry Chain Analysis
7.2 Epoetin-alfa Erythropoietin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Epoetin-alfa Erythropoietin Production Mode & Process
7.4 Epoetin-alfa Erythropoietin Sales and Marketing
7.4.1 Epoetin-alfa Erythropoietin Sales Channels
7.4.2 Epoetin-alfa Erythropoietin Distributors
7.5 Epoetin-alfa Erythropoietin Customers
8 Epoetin-alfa Erythropoietin Market Dynamics
8.1 Epoetin-alfa Erythropoietin Industry Trends
8.2 Epoetin-alfa Erythropoietin Market Drivers
8.3 Epoetin-alfa Erythropoietin Market Challenges
8.4 Epoetin-alfa Erythropoietin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
